From: Responses to fertility treatment among patients with cancer: a retrospective cohort study
Characteristics at cycle start | No Cancer (nā=ā664) | Local Cancer (nā=ā105) | Systemic Cancer (nā=ā42) |
---|---|---|---|
Womanās Age at Stimulation, years (meanāĀ±āSD) | 34.6āĀ±ā4.2 | 33.6āĀ±ā4.8 | 27.1āĀ±ā6.4 |
Baseline Antral Follicle Count (meanāĀ±āSD) (missing, nā=ā48) | 9.4āĀ±ā7.2 | 10.1āĀ±ā7.4 | 7.3āĀ±ā7.5 |
AMH, ng/mL (meanāĀ±āSD) | 3.4āĀ±ā3.3 | 2.8āĀ±ā2.7 | 2.0āĀ±ā2.2 |
CycleĀ Day 2ā4 FSH, mIU/mL (meanāĀ±āSD) (missing, nā=ā91) | 7.2āĀ±ā2.3 | 9.6āĀ±ā19.8 | 9.1āĀ±ā6.3 |
Womanās BMI at Stimulation, kg/m2 (meanāĀ±āSD) | 25.7āĀ±ā4.2 | 26.0āĀ±ā6.3 | 24.9āĀ±ā5.9 |
Womanās Race (n [%]) | |||
āCaucasian | 466 (70.2%) | 88 (86.2%) | 36 (85.7%) |
āOther | 198 (29.8%) | 14 (13.7%) | 6 (14.3%) |
Current Smoker (n [%]) | 17 (2.6%) | 6 (5.7%) | 0 (0%) |
Gravida (n [%]) | 186 (28.3%) | 35(33.3%) | 7 (16.7%) |
Cycle Type (n [%]) | |||
āGnRH antagonist | 88 (13.3%) | 103 (98.1%) | 36 (85.7%) |
āDown-regulation | 533 (80.3%) | 1 (1.0%) | 4 (9.5%) |
āGonadotropin only | 3 (0.5%) | 1 (1.0%) | 2 (4.8%) |
āPoor-responder protocols | 40 (6.0%) | 0 (0%) | 0 (0%) |
Start of Stimulation (n [%]) | |||
āConventional/Early Follicular | 664 (100.0%) | 84 (80.0%) | 25 (59.5%) |
āRandom Start | 0 (0%) | 16 (14.3%) | 17 (40.5%) |
āāLate Follicular | 0 (0%) | 3 (2.9%) | 2 (4.8%) |
āāLuteal | 0 (0%) | 7 (6.7%) | 5 (11.9%) |
Total Motile Post-wash Sperm Count, 106 (meanāĀ±āSD) | 5.66āĀ±ā16.88 | 28.9āĀ±ā33.4 | 34.8āĀ±ā41.5 |
ICSI (n [%]) | 547 (85.6%) | 21 (21.7%) | 4 (11.4%) |